Skip to search formSkip to main contentSkip to account menu

bismuth subcitrate

Known as: bismuth tripotassium dicitrate [Chemical/Ingredient], Bismuth tripotassium dicitrate, BISSUBCIT 
A mineral compound that is used to treat duodenal and gastric ulcers associated with Helicobacter pylori.
National Institutes of Health

Related topics

Related topics

18 relations

Broader (4)

AntacidsAnti-Infective AgentsAnti-Ulcer AgentOrganometallic Compounds
BismuthBlood Coagulation DisordersChickenpoxDrug Allergy

Narrower (3)

Bismuth subcitrate potassiumPyleraVentrisol-polfa

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
Highly Cited
2012
Highly Cited
2012
The effects of some boron compounds against heavy metal toxicity in human blood.
Highly Cited
2005
Highly Cited
2005
Stability of metronidazole, tetracycline HCl and famotidine alone and in combination.
Highly Cited
2003
Highly Cited
2003
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second‐line treatment for Helicobacter pylori infection
Aim : To test the efficacy of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy for the second‐line… 
Review
1990
Review
1990
Bismuth therapy in gastrointestinal diseases.
Highly Cited
1989
Highly Cited
1989
Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.
Fifty consecutive patients with non-ulcer dyspepsia and a Campylobacter associated gastritis (CAG) were randomly assigned to… 
Highly Cited
1987
Highly Cited
1987
Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.
Campylobacter pyloridis colonization of the stomach may be an etiological factor in gastritis and peptic ulceration… 
Highly Cited
1987
Highly Cited
1987
Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
This study compares the gastroprotective effects of colloidal bismuth subcitrate (De-Nol) with those of sucralfate and a… 
Highly Cited
1986
Highly Cited
1986
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
Eighty patients with duodenal ulcer were randomly allocated to treatment with tripotassium dicitrato bismuthate (TDB) tablets or… 
Highly Cited
1981
Highly Cited
1981
DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATE
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)